New research and pharmacovigilance data highlight that while amiodarone remains a highly effective antiarrhythmic, its long-term use carries distinct organ-specific risks that vary by administration ...
Given concerns about rhabdomyolysis in patients treated concurrently with amiodarone and simvastatin, what is the best way to reduce adverse events while maintaining the lipid-lowering effects of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results